Ultra-low price of generic agents in China may weaken patients' drug recognition and compliance.
Ultra-low price of generic agents in China may weaken patients' drug recognition and compliance.
Drug Discov Ther. 2020 Apr 15;:
Authors: Lu S, Cai J, Xu F
Abstract
Drug quantity purchase in China has reshaped the pattern of drug market with lower price of generic drugs and relatively higher price of original brand-name drugs. However, most Chinese people do not trust the safety and efficacy of the generic drugs that sold at a very low price. Ultra-low price of generic agents may weaken patients' drug recognition and compliance, and affect the implementation of drug quantity purchase policy.
PMID: 32295974 [PubMed - as supplied by publisher]
Source: Drug Discoveries and Therapeutics - Category: Drugs & Pharmacology Tags: Drug Discov Ther Source Type: research
More News: China Health | Drugs & Pharmacology